114 related articles for article (PubMed ID: 6144125)
1. Prophylactic effect of neuroleptics in symptom-free schizophrenics: a comparative dose-response study of haloperidol and propericiazine.
Nishikawa T; Tsuda A; Tanaka M; Hoaki Y; Koga I; Uchida Y
Psychopharmacology (Berl); 1984; 82(3):153-6. PubMed ID: 6144125
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effects of neuroleptics in symptom-free schizophrenics: a comparative dose-response study of timiperone and sulpiride.
Nishikawa T; Tanaka M; Tsuda A; Koga I; Uchida Y
Biol Psychiatry; 1989 Apr; 25(7):861-6. PubMed ID: 2655717
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic effect of neuroleptics in symptom-free schizophrenics.
Nishikawa T; Tsuda A; Tanaka M; Koga I; Uchida Y
Psychopharmacology (Berl); 1982; 77(4):301-4. PubMed ID: 6127747
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers.
Nishikawa T; Tsuda A; Tanaka M; Koga I; Uchida Y
Biol Psychiatry; 1985 Nov; 20(11):1161-6. PubMed ID: 3902105
[TBL] [Abstract][Full Text] [Related]
5. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients.
Bechelli LP; Ruffino-Netto A; Hetem G
Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579
[TBL] [Abstract][Full Text] [Related]
6. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
Singh MM; Kay SR
Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
9. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
Singh MM; Kay SR
Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
[TBL] [Abstract][Full Text] [Related]
12. Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
Manchanda R; Hirsch SR
Br J Psychiatry; 1986 Jun; 148():701-7. PubMed ID: 2877702
[TBL] [Abstract][Full Text] [Related]
13. A standard-controlled clinical study with propericiazine in schizophrenic patients.
Ananth JV; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754
[No Abstract] [Full Text] [Related]
14. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky JG; Mahmoud R; Brenner R;
N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
[TBL] [Abstract][Full Text] [Related]
15. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
[TBL] [Abstract][Full Text] [Related]
17. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of neuroleptic medication in older, outpatient schizophrenics. A placebo-controlled, double-blind trial.
Ruskin PE; Nyman G
J Nerv Ment Dis; 1991 Apr; 179(4):212-4. PubMed ID: 1672547
[TBL] [Abstract][Full Text] [Related]
20. Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.
Bechelli LP; Navas-Filho F
Encephale; 1986; 12(3):121-5. PubMed ID: 2876879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
